外分泌胰腺癌患者切除标本检查方案：检查表的基础。美国病理学家学会癌症委员会 - Suppr

Suppr

超能文献

Protocol for the examination of specimens removed from patients with carcinoma of the exocrine pancreas: a basis for checklists. Cancer Committee, College of American Pathologists.

作者信息

Compton C C, Henson D E

机构信息

Department of Pathology, Massachusetts General Hospital, Boston, USA.

出版信息

Arch Pathol Lab Med. 1997 Nov;121(11):1129-36.

PMID:9372738

Abstract

摘要

相似文献

Protocol for the examination of specimens removed from patients with carcinoma of the exocrine pancreas: a basis for checklists. Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 1997 Nov;121(11):1129-36.

Protocol for the examination of specimens removed from patients with esophageal carcinoma. A basis for checklists. The Cancer Committee, College of American Pathologists, and the Task Force on the Examination of Specimens From Patients With Esophageal Cancer.

Arch Pathol Lab Med. 1997 Sep;121(9):925-9.

Protocol for the examination of specimens removed from patients with gastrointestinal lymphoma. A basis for checklists. The Cancer Committee, College of American Pathologists, and the Task Force for Protocols on the Examination of Specimens From Patients With Gastrointestinal Lymphoma.

Arch Pathol Lab Med. 1997 Oct;121(10):1042-7.

Practice protocol for the examination of specimens removed from patients with cancer of the breast: a publication of the Cancer Committee, College of American Pathologists. Members of the Cancer Committee, College of American Pathologists, and the Task Force for Protocols on the Examination of Specimens from Patients with Breast Cancer.

Arch Pathol Lab Med. 1997 Jan;121(1):27-33.

Practice protocol for the examination of specimens removed from patients with carcinoma of the prostate gland. A publication of the cancer committee, college of american pathologists. Task Force on the Examination of Specimens Removed From Patients With Prostate Cancer.

Arch Pathol Lab Med. 1994 Aug;118(8):779-83.

Protocol for the examination of specimens removed from patients with colorectal carcinoma. A basis for checklists. Cancer Committee, College of American Pathologists. Task Force for Protocols on the Examination of Specimens from Patients with Colorectal Cancer.

Arch Pathol Lab Med. 1994 Feb;118(2):122-5.

Mammographically directed breast biopsies: a College of American Pathologists Q-Probes study of clinical physician expectations and of specimen handling and reporting characteristics in 434 institutions.

Arch Pathol Lab Med. 1997 Jan;121(1):11-8.

Protocol for the examination of specimens removed from patients with gastric carcinoma: a basis for checklists. Members of the Cancer Committee, College of American Pathologists, and the Task Force for Protocols on the Examination of Specimens From Patients With Gastric Cancer.

Arch Pathol Lab Med. 1998 Jan;122(1):9-14.

Practice protocol for the examination of specimens removed from patients with carcinoma of the urinary bladder, ureter, renal pelvis, and urethra.

Arch Pathol Lab Med. 1996 Dec;120(12):1103-10.

Protocol for the examination of specimens from patients with carcinoma of the ampulla of Vater: a basis for checklists. Cancer Committee, College of American Pathologists.

Arch Pathol Lab Med. 1997 Jul;121(7):673-7.

引用本文的文献

Survival and pathological response in pancreatic ductal adenocarcinoma after preoperative therapy with PD-1 blockade plus chemoradiotherapy followed by surgical resection.

Ann Med. 2025 Dec;57(1):2541314. doi: 10.1080/07853890.2025.2541314. Epub 2025 Aug 4.

Small pancreatic ductal adenocarcinoma (≤ 2 cm): different imaging and clinicopathologic features according to extrapancreatic extension.

Abdom Radiol (NY). 2025 Feb 14. doi: 10.1007/s00261-025-04831-0.

Efficacy of Neoadjuvant Radiotherapy After Chemotherapy and the Optimal Interval from Radiotherapy to Surgery for Borderline Resectable and Resectable Pancreatic Cancer.

Ann Surg Oncol. 2025 Apr;32(4):2819-2829. doi: 10.1245/s10434-024-16743-2. Epub 2025 Jan 14.

Next‑generation sequencing to identify genetic mutations in pancreatic cancer using intraoperative peritoneal washing fluid.

Oncol Lett. 2024 Feb 2;27(4):139. doi: 10.3892/ol.2024.14272. eCollection 2024 Apr.

Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma.

Cancer Med. 2023 Jun;12(12):12986-12995. doi: 10.1002/cam4.5971. Epub 2023 May 3.

Normalization of tumor markers and a clear resection margin affect progression-free survival of patients with unresectable pancreatic cancer who have undergone conversion surgery.

BMC Cancer. 2023 Jan 14;23(1):49. doi: 10.1186/s12885-023-10529-7.

Neoadjuvant Therapy Is Associated with Improved Chemotherapy Delivery and Overall Survival Compared to Upfront Resection in Pancreatic Cancer without Increasing Perioperative Complications.

Cancers (Basel). 2022 Jan 26;14(3):609. doi: 10.3390/cancers14030609.

Pathological complete response (pCR) with or without the residual intraductal carcinoma component following preoperative treatment for pancreatic cancer: Revisiting the definition of "pCR" from the prognostic standpoint.

Ann Gastroenterol Surg. 2019 Sep 20;3(6):676-685. doi: 10.1002/ags3.12288. eCollection 2019 Nov.

Population-based study of the impact of surgical and adjuvant therapy at the same or a different institution on survival of patients with pancreatic adenocarcinoma.

BJS Open. 2018 Dec 5;3(1):85-94. doi: 10.1002/bjs5.50115. eCollection 2019 Feb.

Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.

Eur Radiol. 2018 Oct;28(10):4265-4273. doi: 10.1007/s00330-018-5410-6. Epub 2018 Apr 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验